Diligence memo · auto-generated · as of July 2, 2026
Endologix Inc /De/
Endologix Inc /De/ looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Endologix Inc /De/ operates in Other Health Care, based in Irvine.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Endologix Inc /De/ has raised $420M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).
Largest single filing: $211M on 2018-08-09.
Most recent recorded round closed around 2018-08-09.
Valuation (modeled)modeled
Provath models Endologix Inc /De/ at approximately $4.8B (range $1.1B–$10.6B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.28× the median modeled value of Series D+ Other Health Care companies in 2016–2018 (7 peers) — value vs value, same stage and era. Within the normal band (128% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 31 months.
Last raise 7.9 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 1.2× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 99% of Other Health Care peers (5377 compared).
Modeled value ranks above 99% of those peers.
Closest niche peers: BNVC Group Holdings, Inc., SYFS Intermediate Holdings, LLC, Allied Integral United, Inc., OneOncology Parent Holdings, LLC, Aeneas Parent Corp..
Peoplefiled
24 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.